Further processing options
A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis
Saved in:
| Published in: | Blood 130(2017), 5, Seite 597-605 |
|---|---|
| Authors and Corporations: | , |
| Title: | A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis/ Vaishali Sanchorawala, Giovanni Palladini, Vishal Kukreti, Jeffrey A. Zonder, Adam D. Cohen, David C. Seldin, Angela Dispenzieri, Arnaud Jaccard, Stefan O. Schönland, Deborah Berg, Huyuan Yang, Neeraj Gupta, Ai-Min Hui, Raymond L. Comenzo and Giampaolo Merlini |
| Type of Resource: | E-Book Component Part |
| Language: | English |
| published: |
May 26, 2017
|
| Series: |
: Blood, 130(2017), 5, Seite 597-605
, volume:130 |
| Source: | Verbunddaten SWB Lizenzfreie Online-Ressourcen |